QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
Log in
OTCMKTS:RNVA

Rennova Health Stock Forecast, Price & News

$0.02
0.00 (0.00 %)
(As of 01/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.02
Now: $0.02
$0.02
50-Day Range
$0.01
MA: $0.02
$0.04
52-Week Range
$0.01
Now: $0.02
$4.00
Volume28.25 million shs
Average Volume22.10 million shs
Market Capitalization$78,091.20
P/E RatioN/A
Dividend YieldN/A
Beta-1.03
Rennova Health, Inc., together with its subsidiaries, engages in the hospital operations in the United States. It operates in two segments, Hospital Operations and Clinical Laboratory Services. The company provides a suite of healthcare related products and services for healthcare providers, patients, and individuals. It also offers diagnostic imaging, radiology, surgery, nuclear medicine, wound care and hyperbaric medicine, intensive care, emergency care, and physical therapy services; and X-ray, mammography, bone densitometry, computed tomography, ultrasound, physical therapy, and laboratory services. In addition, the company provides blood and urine, toxicology, clinical pharmacogenetics, and esoteric testing services. Further, it invests in and develops a suite of software products to its diagnostics business. Additionally, the company owns three hospitals, a physician's office in Tennessee, and a rural clinic in Kentucky. Rennova Health, Inc. was founded in 2005 and is based in West Palm Beach, Florida.

MarketRank

Overall MarketRank

0.50 out of 5 stars

Medical Sector

1518th out of 1,922 stocks

General Medical & Surgical Hospitals Industry

10th out of 12 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RNVA
Previous SymbolNASDAQ:RNVA
CUSIPN/A
Phone561-855-1626
Employees98
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.99 million
Book Value($79.32) per share

Profitability

Net Income$-48,030,000.00
Net Margins-216.27%

Miscellaneous

Market Cap$78,091.20
Next Earnings Date6/25/2021 (Estimated)
OptionableNot Optionable
$0.02
0.00 (0.00 %)
(As of 01/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RNVA News and Ratings via Email

Sign-up to receive the latest news and ratings for RNVA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Rennova Health (OTCMKTS:RNVA) Frequently Asked Questions

How has Rennova Health's stock price been impacted by Coronavirus (COVID-19)?

Rennova Health's stock was trading at $0.0001 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RNVA stock has increased by 19,700.0% and is now trading at $0.0198.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Rennova Health?

Wall Street analysts have given Rennova Health a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Rennova Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Rennova Health's next earnings date?

Rennova Health is scheduled to release its next quarterly earnings announcement on Friday, June 25th 2021.
View our earnings forecast for Rennova Health
.

How were Rennova Health's earnings last quarter?

Rennova Health, Inc. (OTCMKTS:RNVA) announced its earnings results on Monday, November, 16th. The company reported ($54.33) earnings per share for the quarter. The business earned $1.95 million during the quarter.
View Rennova Health's earnings history
.

When did Rennova Health's stock split? How did Rennova Health's stock split work?

Rennova Health shares reverse split on Monday, November 12th 2018. The 1-500 reverse split was announced on Thursday, November 8th 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 9th 2018. An investor that had 100 shares of Rennova Health stock prior to the reverse split would have 0 shares after the split.

Who are some of Rennova Health's key competitors?

What other stocks do shareholders of Rennova Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rennova Health investors own include Neovasc (NVCN), Himax Technologies (HIMX), Precipio (PRPO), CytRx (CYTR), Heat Biologics (HTBX), Biopharmx (BPMX), Delcath Systems (DCTHD), Immune Pharmaceuticals (IMNP), Protalix BioTherapeutics (PLX) and 22nd Century Group (XXII).

Who are Rennova Health's key executives?

Rennova Health's management team includes the following people:
  • Mr. Seamus Lagan, Pres, CEO & Director (Age 52, Pay $399k)
  • Ms. Karen Taylor, Director of HR
  • Mr. Albert F. Lechner, Exec. VP of Sales - Rennova Health Technology Solutions
  • Mr. Michael Alexander, CEO of Jamestown Medical Center, Inc.
  • Mr. Sebastien Sainsbury, Company Sec. & PR
  • Ms. Kristi Dymond, Treasurer

What is Rennova Health's stock symbol?

Rennova Health trades on the OTCMKTS under the ticker symbol "RNVA."

How do I buy shares of Rennova Health?

Shares of RNVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Rennova Health's stock price today?

One share of RNVA stock can currently be purchased for approximately $0.02.

How big of a company is Rennova Health?

Rennova Health has a market capitalization of $78,091.20 and generates $15.99 million in revenue each year. Rennova Health employs 98 workers across the globe.

What is Rennova Health's official website?

The official website for Rennova Health is www.rennovahealth.com.

How can I contact Rennova Health?

Rennova Health's mailing address is 931 Village Boulevard Suite 905, West Palm Beach FL, 33409. The company can be reached via phone at 561-855-1626 or via email at [email protected]

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.